Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
Wheat JC, Weizer AZ, Wolf JS Jr, Lotan Y, Remzi M, Margulis V, Wood CG, Montorsi F, Roscigno M, Kikuchi E, Zigeuner R, Langner C, Bolenz C, Koppie TM, Raman JD, Fernández M, Karakiewizc P, Capitanio U, Bensalah K, Patard JJ, Shariat SF.
Wheat JC, et al. Among authors: wood cg.
Urol Oncol. 2012 May-Jun;30(3):252-8. doi: 10.1016/j.urolonc.2010.01.001. Epub 2010 May 6.
Urol Oncol. 2012.
PMID: 20451416